Financhill
Sell
1

BTOC Quote, Financials, Valuation and Earnings

Last price:
$4.13
Seasonality move :
--
Day range:
$4.12 - $4.74
52-week range:
$3.27 - $8.74
Dividend yield:
0%
P/E ratio:
1,562.26x
P/S ratio:
1.02x
P/B ratio:
4.98x
Volume:
222.5K
Avg. volume:
359.7K
1-year change:
--
Market cap:
$172.4M
Revenue:
$167M
EPS (TTM):
$0.00
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- $9M $56M $135M $167M
Revenue Growth (YoY) -- -- 521.37% 141.02% 23.65%
 
Cost of Revenues -- $7.4M $49.7M $109.3M $148.9M
Gross Profit -- $1.6M $6.3M $25.7M $18.1M
Gross Profit Margin -- 18.07% 11.3% 19.06% 10.83%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $1.1M $3.5M $6.2M $10.2M
Other Inc / (Exp) -- $73.6K $520.8K $829.3K $4.1M
Operating Expenses -- $1.1M $4M $7.2M $11.8M
Operating Income -- $511.6K $2.4M $18.5M $6.3M
 
Net Interest Expenses -- $14.3K $71.5K $78K --
EBT. Incl. Unusual Items -- $570.9K $2.8M $19.3M $10.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $167.6K $841.3K $5.4M $2.9M
Net Income to Company -- $403.3K $2M $13.9M $7.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- $403.3K $2M $13.9M $7.4M
 
Basic EPS (Cont. Ops) -- $0.01 $0.05 $0.33 $0.19
Diluted EPS (Cont. Ops) -- $0.01 $0.05 $0.33 $0.19
Weighted Average Basic Share -- $42M $42M $41.6M $40.2M
Weighted Average Diluted Share -- $42M $42M $42M $40.2M
 
EBITDA -- $762.9K $3.7M $20.7M $12.5M
EBIT -- $583.3K $2.9M $19.3M $10.4M
 
Revenue (Reported) -- $9M $56M $135M $167M
Operating Income (Reported) -- $511.6K $2.4M $18.5M $6.3M
Operating Income (Adjusted) -- $583.3K $2.9M $19.3M $10.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $41.2M $42.5M
Revenue Growth (YoY) -- -- -- 61.77% 3%
 
Cost of Revenues -- -- -- $36M $46.1M
Gross Profit -- -- -- $5.2M -$3.6M
Gross Profit Margin -- -- -- 12.67% -8.49%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $1.9M $3.4M
Other Inc / (Exp) -- -- -- $854K $1.5M
Operating Expenses -- -- -- $2.2M $3.9M
Operating Income -- -- -- $3M -$7.5M
 
Net Interest Expenses -- -- -- $46.9K $15.7K
EBT. Incl. Unusual Items -- -- -- $3.8M -$6.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $1.1M -$1.4M
Net Income to Company -- -- -- $2.8M -$4.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $2.8M -$4.6M
 
Basic EPS (Cont. Ops) -- -- -- $0.07 -$0.11
Diluted EPS (Cont. Ops) -- -- -- $0.07 -$0.11
Weighted Average Basic Share -- -- -- $41.6M $41.6M
Weighted Average Diluted Share -- -- -- $42M $41.7M
 
EBITDA -- -- -- $4.3M -$5.4M
EBIT -- -- -- $3.9M -$6.1M
 
Revenue (Reported) -- -- -- $41.2M $42.5M
Operating Income (Reported) -- -- -- $3M -$7.5M
Operating Income (Adjusted) -- -- -- $3.9M -$6.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $148.6M $168.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $123.1M $159M
Gross Profit -- -- -- $25.5M $9.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $7M $12.4M
Other Inc / (Exp) -- -- -- $1.4M $5M
Operating Expenses -- -- -- $8M $13.8M
Operating Income -- -- -- $17.5M -$4.6M
 
Net Interest Expenses -- -- -- $99.4K --
EBT. Incl. Unusual Items -- -- -- $18.8M $461.6K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $5.5M $423K
Net Income to Company -- -- -- -- $38.6K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $13.3M $38.6K
 
Basic EPS (Cont. Ops) -- -- -- $0.32 $0.00
Diluted EPS (Cont. Ops) -- -- -- $0.32 $0.00
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- $20M $2.7M
EBIT -- -- -- $18.8M $504.8K
 
Revenue (Reported) -- -- -- $148.6M $168.2M
Operating Income (Reported) -- -- -- $17.5M -$4.6M
Operating Income (Adjusted) -- -- -- $18.8M $504.8K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $41.2M $42.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $36M $46.1M
Gross Profit -- -- -- $5.2M -$3.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $1.9M $3.4M
Other Inc / (Exp) -- -- -- $854K $1.5M
Operating Expenses -- -- -- $2.2M $3.9M
Operating Income -- -- -- $3M -$7.5M
 
Net Interest Expenses -- -- -- $46.9K $15.7K
EBT. Incl. Unusual Items -- -- -- $3.8M -$6.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $1.1M -$1.4M
Net Income to Company -- -- -- $2.8M -$4.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $2.8M -$4.6M
 
Basic EPS (Cont. Ops) -- -- -- $0.07 -$0.11
Diluted EPS (Cont. Ops) -- -- -- $0.07 -$0.11
Weighted Average Basic Share -- -- -- $41.6M $41.6M
Weighted Average Diluted Share -- -- -- $42M $41.7M
 
EBITDA -- -- -- $4.3M -$5.4M
EBIT -- -- -- $3.9M -$6.1M
 
Revenue (Reported) -- -- -- $41.2M $42.5M
Operating Income (Reported) -- -- -- $3M -$7.5M
Operating Income (Adjusted) -- -- -- $3.9M -$6.1M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents -- $2M $2.2M $6.6M $7.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $3.1M $9.5M $17.4M $25.3M
Inventory -- -- -- -- --
Prepaid Expenses -- $374.8K $399.5K $796.9K $1.1M
Other Current Assets -- $263.6K $265.8K $1.6M $1.6M
Total Current Assets -- $5.8M $12.6M $30.1M $38M
 
Property Plant And Equipment -- $3.1M $48.4M $57.8M $123.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- $48.7K $104.7K $128K $92.7K
Other Long-Term Assets -- -- -- -- $2.8M
Total Assets -- $8.9M $61.1M $88.6M $167M
 
Accounts Payable -- $737.4K $3.9M $7.5M $6M
Accrued Expenses -- $131.7K $129.2K $263.4K $405.3K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- $74.7K $7.7M $12.3M $24.4M
Other Current Liabilities -- $11.3K $83.1K $78.3K $52.3K
Total Current Liabilities -- $1.3M $15.8M $24.5M $33M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- $1.4M $50.5M $63.2M $127.8M
 
Common Stock -- $400 $400 $400 $420
Other Common Equity Adj -- -- -- -- --
Common Equity -- $7.5M $10.6M $25.3M $39.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $7.5M $10.6M $25.3M $39.2M
 
Total Liabilities and Equity -- $8.9M $61.1M $88.6M $167M
Cash and Short Terms -- $2M $2.2M $6.6M $7.9M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $2.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- $25.2M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $812.7K
Other Current Assets -- -- -- -- $1.9M
Total Current Assets -- -- -- -- $31.7M
 
Property Plant And Equipment -- -- -- -- $119M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- $83.9K
Other Long-Term Assets -- -- -- -- $2.9M
Total Assets -- -- -- -- $157.5M
 
Accounts Payable -- -- -- -- $5.4M
Accrued Expenses -- -- -- -- $779.7K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $26.4M
Other Current Liabilities -- -- -- -- $58.7K
Total Current Liabilities -- -- -- -- $33.9M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $122.9M
 
Common Stock -- -- -- -- $420
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $34.6M
 
Total Liabilities and Equity -- -- -- -- $157.5M
Cash and Short Terms -- -- -- -- $2.9M
Total Debt -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- $403.3K $2M $13.9M $7.4M
Depreciation & Amoritzation -- $179.6K $830.6K $1.3M $2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -$3M -$6.6M -$8.5M -$8.2M
Change in Inventories -- -- -- -- --
Cash From Operations -- -$1.5M $542.9K $11.8M $3M
 
Capital Expenditures -- $3.1M $4M $1.9M $5.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$3.1M -$4M -$4.3M -$7.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$21.5K -$147.6K -$208.5K -$211.6K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $2.7M -$3.4M -$439.3K
Cash From Financing -- $6.3M $3.6M -$3.2M $7.8M
 
Beginning Cash (CF) -- $286K $2M $2.2M $6.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $1.7M $222.7K $4.3M $3.4M
Ending Cash (CF) -- $2M $2.2M $6.6M $10M
 
Levered Free Cash Flow -- -$4.5M -$3.4M $9.9M -$2.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- $2.8M -$4.6M
Depreciation & Amoritzation -- -- -- $442.2K $626K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- $569.1K $160.6K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- $3.1M -$3.6M
 
Capital Expenditures -- -- -- $1.1M $1.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$2.2M -$1.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$54.9K -$44.8K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $899.3K --
Cash From Financing -- -- -- $939.3K -$44.8K
 
Beginning Cash (CF) -- -- -- $6.6M $10M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $1.8M -$5M
Ending Cash (CF) -- -- -- $8.4M $5M
 
Levered Free Cash Flow -- -- -- $1.9M -$5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- $38.6K
Depreciation & Amoritzation -- -- -- -- $2.2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- -$8.6M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$3.6M
 
Capital Expenditures -- -- -- $1.1M $5.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$6.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- -$201.5K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- $6.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- -$3.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- $2.8M -$4.6M
Depreciation & Amoritzation -- -- -- $442.2K $626K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- $569.1K $160.6K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- $3.1M -$3.6M
 
Capital Expenditures -- -- -- $1.1M $1.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$2.2M -$1.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$54.9K -$44.8K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $899.3K --
Cash From Financing -- -- -- $939.3K -$44.8K
 
Beginning Cash (CF) -- -- -- $6.6M $10M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $1.8M -$5M
Ending Cash (CF) -- -- -- $8.4M $5M
 
Levered Free Cash Flow -- -- -- $1.9M -$5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock